Aura Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AURA and other ETFs, options, and stocks.About AURA
Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities.
CEOElisabet de los Pinos
CEOElisabet de los Pinos
Employees89
Employees89
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2007
Founded2007
Employees89
Employees89
AURA Key Statistics
Market cap387.18M
Market cap387.18M
Price-Earnings ratio-4.34
Price-Earnings ratio-4.34
Dividend yield—
Dividend yield—
Average volume95.66K
Average volume95.66K
High today$7.95
High today$7.95
Low today$7.63
Low today$7.63
Open price$7.72
Open price$7.72
Volume94.11K
Volume94.11K
52 Week high$12.35
52 Week high$12.35
52 Week low$5.99
52 Week low$5.99
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%